Home > Publications database > Erratum to: Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I study > print

001     128930
005     20240228143358.0
024 7 _ |a 10.1007/s00280-016-3023-9
|2 doi
024 7 _ |a WOS:000376985500021
|2 WOS
024 7 _ |a 0344-5704
|2 ISSN
024 7 _ |a 0943-9404
|2 ISSN
024 7 _ |a 1432-0843
|2 ISSN
024 7 _ |a altmetric:6829251
|2 altmetric
024 7 _ |a pmid:27094900
|2 pmid
037 _ _ |a DKFZ-2017-04942
082 _ _ |a 610
100 1 _ |a König, Miriam
|b 0
245 _ _ |a Erratum to: Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I study
260 _ _ |a Berlin
|c 2016
|b Springer62507
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1531141192_16864
|2 PUB:(DE-HGF)
|x Erratum/Correction
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
542 _ _ |i 2016-04-19
|2 Crossref
|u http://www.springer.com/tdm
588 _ _ |a Dataset connected to Web of Science, Web of Science, , CrossRef
700 1 _ |a von Hagens, Cornelia
|b 1
700 1 _ |a Hoth, Sebastian
|b 2
700 1 _ |a Baumann, Ingo
|b 3
700 1 _ |a Walter-Sack, Ingeborg
|b 4
700 1 _ |a Edler, Lutz
|0 P:(DE-He78)621efe295db6fdfa7f9f95011a5ea943
|b 5
|u dkfz
700 1 _ |a Sertel, Serkan
|b 6
773 1 8 |a 10.1007/s00280-016-3023-9
|b Springer Science and Business Media LLC
|d 2016-04-19
|n 6
|p 1321-1321
|3 journal-article
|2 Crossref
|t Cancer Chemotherapy and Pharmacology
|v 77
|y 2016
|x 0344-5704
773 _ _ |a 10.1007/s00280-016-3023-9
|g Vol. 77, no. 6, p. 1321 - 1321
|0 PERI:(DE-600)1458488-8
|n 6
|p 1321-1321
|t Cancer chemotherapy and pharmacology
|v 77
|y 2016
|x 0344-5704
909 C O |p VDB
|o oai:inrepo02.dkfz.de:128930
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)621efe295db6fdfa7f9f95011a5ea943
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2016
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER CHEMOTH PHARM : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)C060-20160331
|k C060
|l Biostatistik
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C060-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21